Study of Polymorphisms in pear1 Gene Link to Platelet Activation and Signaling Pathway Variations
NCT01352923 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-06-28
Summary
In this study PEAR1 polymorphisms effects will be analyze in blood platelets to determine how PEAR1 regulates platelet activation.
Conditions
- Platelet Function
Interventions
- OTHER
-
blood test
preparation of blood platelets
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Marc Hoylaerts · KU Leuven
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
Countries
- Belgium
Study Locations
More Related Trials
-
Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia
NCT03492515 ·Status: UNKNOWN ·Phase: PHASE3
-
Towards Improved Diagnostics for Suspected Platelet Function Disorders
NCT05985668 ·Status: RECRUITING
-
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
NCT04003220 ·Status: UNKNOWN
-
The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia
NCT01869049 ·Status: WITHDRAWN
-
Platelet Volunteers, Longitudinal and Multi-omic Study
NCT07137429 ·Status: RECRUITING
-
Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients
NCT00759083 ·Status: WITHDRAWN ·Phase: PHASE4
-
Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation
NCT00903929 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia
NCT04896528 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia
NCT02227693 ·Status: COMPLETED ·Phase: PHASE2
-
Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure
NCT03554759 ·Status: TERMINATED
-
Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia
NCT06033300 ·Status: RECRUITING ·Phase: NA
-
Clinical Performance Evaluation of T-TAS 01 PL Chip
NCT03621020 ·Status: COMPLETED
-
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
NCT00151866 ·Status: COMPLETED ·Phase: PHASE3
-
Alteration of Different Immune Parameters in Immune Thrombocytopenia (ITP) Patients Receiving Eltrombopag Treatment
NCT01864512 ·Status: WITHDRAWN
-
Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada
NCT03784898 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652 ·Status: RECRUITING
-
Lovaza's Effect on the Activation of Platelets
NCT00515541 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
NCT00005652 ·Status: COMPLETED ·Phase: PHASE2
-
Research for Plasma Biomarkers Associated With Fatigue in Thrombocytopenic Patients
NCT06979765 ·Status: RECRUITING ·Phase: NA
-
Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia
NCT01230775 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Etiology of Aplastic Anemia and Related Dyscrasias
NCT00005302 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)
NCT05096403 ·Status: COMPLETED ·Phase: PHASE3
-
Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)
NCT04949009 ·Status: UNKNOWN
-
A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease
NCT05193201 ·Status: UNKNOWN ·Phase: PHASE1
-
Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure
NCT01972529 ·Status: COMPLETED ·Phase: PHASE3